Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
Add more filters










Publication year range
2.
Neuron ; 110(10): 1671-1688.e6, 2022 05 18.
Article in English | MEDLINE | ID: mdl-35294901

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is characterized by motor neuron degeneration accompanied by aberrant accumulation and loss of function of the RNA-binding protein TDP43. Thus far, it remains unresolved to what extent TDP43 loss of function directly contributes to motor system dysfunction. Here, we employed gene editing to find whether the mouse ortholog of the TDP43-regulated gene STMN2 has an important function in maintaining the motor system. Both mosaic founders and homozygous loss-of-function Stmn2 mice exhibited neuromuscular junction denervation and fragmentation, resulting in muscle atrophy and impaired motor behavior, accompanied by an imbalance in neuronal microtubule dynamics in the spinal cord. The introduction of human STMN2 through BAC transgenesis was sufficient to rescue the motor phenotypes observed in Stmn2 mutant mice. Collectively, our results demonstrate that disrupting the ortholog of a single TDP43-regulated RNA is sufficient to cause substantial motor dysfunction, indicating that disruption of TDP43 function is likely a contributor to ALS.


Subject(s)
Amyotrophic Lateral Sclerosis , Stathmin , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/metabolism , Animals , Disease Models, Animal , Homozygote , Mice , Mice, Transgenic , Motor Neurons/metabolism , Neuromuscular Junction/metabolism , Stathmin/genetics , Stathmin/metabolism
3.
JCI Insight ; 6(3)2021 02 08.
Article in English | MEDLINE | ID: mdl-33351783

ABSTRACT

The cohesin complex plays an essential role in chromosome maintenance and transcriptional regulation. Recurrent somatic mutations in the cohesin complex are frequent genetic drivers in cancer, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Here, using genetic dependency screens of stromal antigen 2-mutant (STAG2-mutant) AML, we identified DNA damage repair and replication as genetic dependencies in cohesin-mutant cells. We demonstrated increased levels of DNA damage and sensitivity of cohesin-mutant cells to poly(ADP-ribose) polymerase (PARP) inhibition. We developed a mouse model of MDS in which Stag2 mutations arose as clonal secondary lesions in the background of clonal hematopoiesis driven by tet methylcytosine dioxygenase 2 (Tet2) mutations and demonstrated selective depletion of cohesin-mutant cells with PARP inhibition in vivo. Finally, we demonstrated a shift from STAG2- to STAG1-containing cohesin complexes in cohesin-mutant cells, which was associated with longer DNA loop extrusion, more intermixing of chromatin compartments, and increased interaction with PARP and replication protein A complex. Our findings inform the biology and therapeutic opportunities for cohesin-mutant malignancies.


Subject(s)
Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Chromosomal Proteins, Non-Histone/genetics , Chromosomal Proteins, Non-Histone/metabolism , DNA Repair/genetics , Leukemia, Myeloid, Acute/genetics , Leukemia, Myeloid, Acute/metabolism , Mutation , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/metabolism , Animals , Cell Line, Tumor , Chromatin/genetics , Chromatin/metabolism , DNA Damage , Disease Models, Animal , Female , Humans , K562 Cells , Leukemia, Myeloid, Acute/drug therapy , Male , Mice , Mice, Inbred C57BL , Mice, Inbred NOD , Mice, Mutant Strains , Mice, SCID , Mice, Transgenic , Myelodysplastic Syndromes/drug therapy , Nuclear Proteins/genetics , Phthalazines/pharmacology , Poly(ADP-ribose) Polymerase Inhibitors/pharmacology , U937 Cells , Xenograft Model Antitumor Assays , Cohesins
4.
Cell Rep ; 15(11): 2488-99, 2016 06 14.
Article in English | MEDLINE | ID: mdl-27264184

ABSTRACT

BRCA1/2 proteins function in homologous recombination (HR)-mediated DNA repair and cooperate with Fanconi anemia (FA) proteins to maintain genomic integrity through replication fork stabilization. Loss of BRCA1/2 proteins results in DNA repair deficiency and replicative stress, leading to genomic instability and enhanced sensitivity to DNA-damaging agents. Recent studies have shown that BRCA1/2-deficient tumors upregulate Polθ-mediated alternative end-joining (alt-EJ) repair as a survival mechanism. Whether other mechanisms maintain genomic integrity upon loss of BRCA1/2 proteins is currently unknown. Here we show that BRCA1/2-deficient tumors also upregulate FANCD2 activity. FANCD2 is required for fork protection and fork restart in BRCA1/2-deficient tumors. Moreover, FANCD2 promotes Polθ recruitment at sites of damage and alt-EJ repair. Finally, loss of FANCD2 in BRCA1/2-deficient tumors enhances cell death. These results reveal a synthetic lethal relationship between FANCD2 and BRCA1/2, and they identify FANCD2 as a central player orchestrating DNA repair pathway choice at the replication fork.


Subject(s)
BRCA1 Protein/deficiency , BRCA2 Protein/deficiency , DNA End-Joining Repair , DNA Replication , Fanconi Anemia Complementation Group D2 Protein/metabolism , Neoplasms/genetics , Neoplasms/pathology , Animals , BRCA1 Protein/metabolism , BRCA2 Protein/metabolism , Carrier Proteins/metabolism , Cell Line, Tumor , Cell Survival , DNA End-Joining Repair/genetics , DNA Replication/genetics , DNA-Directed DNA Polymerase/metabolism , Endodeoxyribonucleases , Genomic Instability , Humans , Mice, Nude , Mutation/genetics , Nuclear Proteins/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Ubiquitination , Up-Regulation/genetics , DNA Polymerase theta
5.
Environ Mol Mutagen ; 57(4): 282-7, 2016 May.
Article in English | MEDLINE | ID: mdl-27040722

ABSTRACT

Cobalt is a toxic metal used in various industrial applications leading to adverse lung effects by inhalation. Cobalt is considered a possible human carcinogen with the lung being a primary target. However, few studies have considered cobalt-induced toxicity in human lung cells, especially normal lung epithelial cells. Therefore, in this study, we sought to determine the cytotoxicity and genotoxicity of particulate and soluble cobalt in normal primary human lung epithelial cells. Cobalt oxide and cobalt chloride were used as representative particulate and soluble cobalt compounds, respectively. Exposure to both particulate and soluble cobalt induced a concentration-dependent increase in cytotoxicity, genotoxicity, and intracellular cobalt ion levels. Based on intracellular cobalt ion levels, we found that soluble and particulate cobalt induced similar cytotoxicity while soluble cobalt was more genotoxic than particulate cobalt. These data indicate that cobalt compounds are cytotoxic and genotoxic to human lung epithelial cells.


Subject(s)
Cobalt/toxicity , Cytotoxins/toxicity , Epithelial Cells/drug effects , Lung/cytology , Lung/drug effects , Mutagens/toxicity , Oxides/toxicity , Cell Line , Chromosome Aberrations/chemically induced , DNA Damage/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Humans , Lung/metabolism , Lung/pathology , Particle Size , Solubility
6.
Toxicol Appl Pharmacol ; 296: 54-60, 2016 Apr 01.
Article in English | MEDLINE | ID: mdl-26908176

ABSTRACT

Numerous metals are well-known human bladder carcinogens. Despite the significant occupational and public health concern of metals and bladder cancer, the carcinogenic mechanisms remain largely unknown. Chromium, in particular, is a metal of concern as incidences of bladder cancer have been found elevated in chromate workers, and there is an increasing concern for patients with metal hip implants. However, the impact of hexavalent chromium (Cr(VI)) on bladder cells has not been studied. We compared chromate toxicity in two bladder cell lines; primary human urothelial cells and hTERT-immortalized human urothelial cells. Cr(VI) induced a concentration- and time-dependent increase in chromosome damage in both cell lines, with the hTERT-immortalized cells exhibiting more chromosome damage than the primary cells. Chronic exposure to Cr(VI) also induced a concentration-dependent increase in aneuploid metaphases in both cell lines which was not observed after a 24h exposure. Aneuploidy induction was higher in the hTERT-immortalized cells. When we correct for uptake, Cr(VI) induces a similar amount of chromosome damage and aneuploidy suggesting that the differences in Cr(VI) sensitivity between the two cells lines were due to differences in uptake. The increase in chromosome instability after chronic chromate treatment suggests this may be a mechanism for chromate-induced bladder cancer, specifically, and may be a mechanism for metal-induced bladder cancer, in general.


Subject(s)
Chromium/toxicity , Chromosomal Instability/drug effects , Chromosomal Instability/physiology , Urothelium/drug effects , Urothelium/physiology , Cells, Cultured , DNA Damage/drug effects , DNA Damage/physiology , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Epithelial Cells/pathology , Epithelial Cells/physiology , Humans , Urothelium/pathology
7.
Toxicol Sci ; 147(2): 490-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26293554

ABSTRACT

Particulate hexavalent chromium (Cr(VI)) is a well-established human lung carcinogen. Lung tumors are characterized by structural and numerical chromosome instability. Centrosome amplification is a phenotype commonly found in solid tumors, including lung tumors, which strongly correlates with chromosome instability. Human lung cells exposed to Cr(VI) exhibit centrosome amplification but the underlying phenotypes and mechanisms remain unknown. In this study, we further characterize the phenotypes of Cr(VI)-induced centrosome abnormalities. We show that Cr(VI)-induced centrosome amplification correlates with numerical chromosome instability. We also show chronic exposure to particulate Cr(VI) induces centrosomes with supernumerary centrioles and acentriolar centrosomes in human lung cells. Moreover, chronic exposure to particulate Cr(VI) affects the timing of important centriolar events. Specifically, chronic exposure to particulate Cr(VI) causes premature centriole disengagement in S and G2 phase cells. It also induces premature centrosome separation in interphase. Altogether, our data suggest that chronic exposure to particulate Cr(VI) targets the protein linkers that hold centrioles together. These centriolar linkers are important for key events of the centrosome cycle and their premature disruption might underlie Cr(VI)-induced centrosome amplification.


Subject(s)
Centrioles/drug effects , Centrosome/drug effects , Chromium/toxicity , Lung/drug effects , Particulate Matter/toxicity , Cell Line , Chromates/administration & dosage , Chromates/toxicity , Chromium/administration & dosage , Chromosomal Instability/drug effects , Humans , Lung/cytology , Particulate Matter/administration & dosage , Zinc Compounds/administration & dosage , Zinc Compounds/toxicity
8.
Biol Trace Elem Res ; 166(1): 49-56, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25805272

ABSTRACT

Hexavalent chromium Cr(VI) is a known human lung carcinogen, with solubility playing an important role in its carcinogenic potency. Dermal exposure to Cr(VI) is common and has been associated with skin damage; however, no link between chromate exposure and skin cancer has been found. In this study, we compared the cytotoxic and clastogenic effects of Cr(VI) and its impacts on cell cycle progression in human lung and skin fibroblasts. We found human skin cells arrested earlier in their cell cycle and exhibit more cytotoxicity than human lung cells, despite taking up similar amounts of Cr. These outcomes are consistent with a hypothesis that different cellular and molecular responses underlie the differences in carcinogenic outcome in these two tissues.


Subject(s)
Cell Cycle Checkpoints/drug effects , Chromium/toxicity , Environmental Pollutants/toxicity , Fibroblasts/drug effects , Lung/drug effects , Skin/drug effects , Cell Culture Techniques , Cell Cycle Checkpoints/genetics , Cell Line , Cell Survival/drug effects , Cell Survival/genetics , Chromium/chemistry , Environmental Pollutants/chemistry , Humans , Lung/cytology , Organ Specificity , Skin/cytology , Solubility
9.
Toxicol Sci ; 142(1): 117-25, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25173789

ABSTRACT

The aim of this study was to focus on hexavalent chromium, [Cr(VI)], a chemical carcinogen and major public health concern, and consider its ability to impact DNA double strand break repair. We further focused on particulate Cr(VI), because it is the more potent carcinogenic form of Cr(VI). DNA double strand break repair serves to protect cells against the detrimental effects of DNA double strand breaks. For particulate Cr(VI), data show DNA double strand break repair must be overcome for neoplastic transformation to occur. Acute Cr(VI) exposures reveal a robust DNA double strand break repair response, however, longer exposures have not been considered. Using the comet assay, we found longer exposures to particulate zinc chromate induced concentration-dependent increases in DNA double strand breaks indicating breaks were occurring throughout the exposure time. Acute (24 h) exposure induced DNA double strand break repair signaling by inducing Mre11 foci formation, ATM phosphorylation and phosphorylated ATM foci formation, Rad51 protein levels and Rad51 foci formation. However, longer exposures reduced the Rad51 response. These data indicate a major chemical carcinogen can simultaneously induce DNA double strand breaks and alter their repair and describe a new and important aspect of the carcinogenic mechanism for Cr(VI).


Subject(s)
Carcinogenesis/drug effects , Carcinogens/toxicity , Chromates/toxicity , DNA Breaks, Double-Stranded , Lung/drug effects , Rad51 Recombinase/genetics , Recombinational DNA Repair , Zinc Compounds/toxicity , Carcinogenesis/genetics , Cell Culture Techniques , Cell Line , Chromosome Aberrations/chemically induced , Comet Assay , Humans , Lung/metabolism , Lung/pathology , Mutagens/toxicity , Time Factors
10.
Toxicol Appl Pharmacol ; 278(3): 259-65, 2014 Aug 01.
Article in English | MEDLINE | ID: mdl-24823294

ABSTRACT

Cobalt exposure is increasing as cobalt demand rises worldwide due to its use in enhancing rechargeable battery efficiency, super-alloys, and magnetic products. Cobalt is considered a possible human carcinogen with the lung being a primary target. However, few studies have considered cobalt-induced toxicity in human lung cells. Therefore, in this study, we sought to determine the cytotoxicity and genotoxicity of particulate and soluble cobalt in human lung cells. Cobalt oxide and cobalt chloride were used as representative particulate and soluble cobalt compounds, respectively. Exposure to both particulate and soluble cobalt induced a concentration-dependent increase in cytotoxicity, genotoxicity, and intracellular cobalt ion levels. Based on intracellular cobalt ion levels, we found that soluble cobalt was more cytotoxic than particulate cobalt while particulate and soluble cobalt induced similar levels of genotoxicity. However, soluble cobalt induced cell cycle arrest indicated by the lack of metaphases at much lower intracellular cobalt concentrations compared to cobalt oxide. Accordingly, we investigated the role of particle internalization in cobalt oxide-induced toxicity and found that particle-cell contact was necessary to induce cytotoxicity and genotoxicity after cobalt exposure. These data indicate that cobalt compounds are cytotoxic and genotoxic to human lung fibroblasts, and solubility plays a key role in cobalt-induced lung toxicity.


Subject(s)
Carcinogens, Environmental/toxicity , Cobalt/toxicity , Lung/drug effects , Mutagens/toxicity , Biological Transport , Carcinogens, Environmental/analysis , Carcinogens, Environmental/chemistry , Carcinogens, Environmental/metabolism , Cell Cycle , Cell Line , Cell Survival/drug effects , Clone Cells , Cobalt/analysis , Cobalt/chemistry , Cobalt/metabolism , DNA Fragmentation/drug effects , Humans , Lung/chemistry , Lung/metabolism , Mutagens/analysis , Mutagens/chemistry , Mutagens/metabolism , Osmolar Concentration , Oxides/analysis , Oxides/chemistry , Oxides/metabolism , Oxides/toxicity , Particle Size , Phagocytosis/drug effects , Solubility
11.
Mutat Res ; 762: 1-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24561002

ABSTRACT

Depleted uranium (DU) is extensively used in both industry and military applications. The potential for civilian and military personnel exposure to DU is rising, but there are limited data on the potential health hazards of DU exposure. Previous laboratory research indicates DU is a potential carcinogen, but epidemiological studies remain inconclusive. DU is genotoxic, inducing DNA double strand breaks, chromosome damage and mutations, but the mechanisms of genotoxicity or repair pathways involved in protecting cells against DU-induced damage remain unknown. The purpose of this study was to investigate the effects of homologous recombination repair deficiency on DU-induced genotoxicity using RAD51D and XRCC3-deficient Chinese hamster ovary (CHO) cell lines. Cells deficient in XRCC3 (irs1SF) exhibited similar cytotoxicity after DU exposure compared to wild-type (AA8) and XRCC3-complemented (1SFwt8) cells, but DU induced more break-type and fusion-type lesions in XRCC3-deficient cells compared to wild-type and XRCC3-complemented cells. Surprisingly, loss of RAD51D did not affect DU-induced cytotoxicity or genotoxicity. DU induced selective X-chromosome fragmentation irrespective of RAD51D status, but loss of XRCC3 nearly eliminated fragmentation observed after DU exposure in wild-type and XRCC3-complemented cells. Thus, XRCC3, but not RAD51D, protects cells from DU-induced breaks and fusions and also plays a role in DU-induced chromosome fragmentation.


Subject(s)
Chromosome Aberrations/radiation effects , Chromosomes, Mammalian/radiation effects , Mutagens/pharmacology , Recombinational DNA Repair , Uranium/pharmacology , Animals , CHO Cells , Chromosomes, Mammalian/chemistry , Cricetulus , DNA Breaks, Double-Stranded/drug effects , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Genetic Complementation Test
12.
Mutat Res ; 735(1-2): 51-5, 2012 Jul 01.
Article in English | MEDLINE | ID: mdl-22583656

ABSTRACT

Inappropriate survival signaling after DNA damage may facilitate clonal expansion of genetically compromised cells, and it is known that protein tyrosine phosphatase (PTP) inhibitors activate key survival pathways. In this study we employed the genotoxicant, hexavalent chromium [Cr(VI)], which is a well-documented carcinogen of occupational and environmental concern. Cr(VI) induces a complex array of DNA damage, including DNA double strand breaks (DSBs). We recently reported that PTP inhibition bypassed cell cycle arrest and abrogated Cr(VI)-induced clonogenic lethality. Notably, PTP inhibition resulted in an increase in forward mutations at the HPRT locus, supporting the hypothesis that PTP inhibition in the presence of DNA damage may lead to genomic instability (GIN), via cell cycle checkpoint bypass. The aim of the present study was to determine the effect of PTP inhibition on DNA DSB formation and chromosomal integrity after Cr(VI) exposure. Diploid human lung fibroblasts were treated with Cr(VI) in the presence or absence of the PTP inhibitor, sodium orthovanadate, for up to 24h, and cells were analyzed for DNA DSBs and chromosomal damage. Cr(VI) treatment induced a rapid increase in DNA DSBs, and a significant increase in total chromosomal damage (chromatid breaks and gaps) after 24h. In sharp contrast, PTP inhibition abrogated both DNA DSBs and chromosomal damage after Cr(VI) treatment. In summary, PTP inhibition in the face of Cr(VI) genotoxic stress decreases chromosomal instability (CIN) but increases mutagenesis, which we postulate to be a result of error-prone DNA repair.


Subject(s)
Chromosomal Instability/drug effects , Genomic Instability/drug effects , Protein Tyrosine Phosphatases/antagonists & inhibitors , Chromium/toxicity , DNA Breaks, Double-Stranded , DNA Damage , Fibroblasts , Humans , Lung/cytology
13.
Comp Biochem Physiol C Toxicol Pharmacol ; 155(1): 143-50, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21466859

ABSTRACT

Chromium (Cr) is a global marine pollutant, present in marine mammal tissues. Hexavalent chromium [Cr(VI)] is a known human carcinogen. In this study, we compare the cytotoxic and clastogenic effects of Cr(VI) in human (Homo sapiens) and sperm whale (Physeter macrocephalus) skin fibroblasts. Our data show that increasing concentrations of both particulate and soluble Cr(VI) induce increasing amounts of cytotoxicity and clastogenicity in human and sperm whale skin cells. Furthermore, the data show that sperm whale cells are resistant to these effects exhibiting less cytotoxicity and genotoxicity than the human cells. Differences in Cr uptake accounted for some but not all of the differences in particulate and soluble Cr(VI) genotoxicity, although it did explain the differences in particulate Cr(VI) cytotoxicity. Altogether, the data indicate that Cr(VI) is a genotoxic threat to whales, but also suggest that whales have evolved cellular mechanisms to protect them against the genotoxicity of environmental agents such as Cr(VI).


Subject(s)
Chromates/toxicity , Chromium/toxicity , Chromosome Aberrations/chemically induced , Lead/toxicity , Sodium Compounds/toxicity , Whales/genetics , Animals , Cells, Cultured , Female , Humans , Metaphase , Mutagenicity Tests , Particulate Matter/toxicity , Solubility , Species Specificity , Whales/physiology
14.
Biochem Soc Trans ; 38(6): 1687-90, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21118148

ABSTRACT

Exposure to toxic and carcinogenic metals is widespread; however, their mechanisms of action remain largely unknown. One potential mechanism for metal-induced carcinogenicity and toxicity is centrosome amplification. Here we review the mechanisms for metal-induced centrosome amplification, including arsenic, chromium, mercury and nano-titanium dioxide.


Subject(s)
Arsenic/toxicity , Centrosome/drug effects , Centrosome/metabolism , Chromium/toxicity , Mercury/toxicity , Titanium/toxicity , Animals , Carcinogens/toxicity , Cell Line , Environmental Exposure , Humans , Nanostructures/toxicity , Titanium/chemistry
15.
Article in English | MEDLINE | ID: mdl-20211760

ABSTRACT

In this study we directly compared soluble and particulate chromate cytotoxicity and genotoxicity in human (Homo sapiens) and sea lion (Eumetopias jubatus) lung fibroblasts. Our results show that hexavalent chromium induces increased cell death and chromosome damage in both human and sea lion cells with increasing intracellular chromium ion levels. The data further indicate that both sodium chromate and lead chromate are less cytotoxic and genotoxic to sea lion cells than human cells, based on an administered dose. Differences in chromium ion uptake explained some but not all of the reduced amounts of sodium chromate-induced cell death. By contrast, uptake differences could explain the differences in sodium chromate-induced chromosome damage and particulate chromate-induced toxicity. Altogether they indicate that while hexavalent chromium induces similar toxic effects in sea lion and human cells, there are different mechanisms underlying the toxic outcomes.


Subject(s)
Chromium/toxicity , Cytotoxins/toxicity , Fibroblasts/drug effects , Lung/drug effects , Sea Lions , Animals , Cell Line , Cells, Cultured , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Lung/metabolism , Lung/pathology , Mutagenicity Tests/methods , Sea Lions/metabolism , Species Specificity
16.
Chem Res Toxicol ; 23(2): 386-95, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-20030412

ABSTRACT

Hexavalent chromium (Cr(VI)) compounds are known human lung carcinogens. Solubility plays an important role in its carcinogenicity with the particulate or insoluble form being the most potent. Of the particulate Cr(VI) compounds, zinc chromate appears to be the most potent carcinogen; however, very few studies have investigated its carcinogenic mechanism. In this study, we investigated the ability of chronic exposure to zinc chromate to induce numerical chromosome instability. We found no increase in aneuploidy after a 24 h exposure to zinc chromate, but with more chronic exposures, zinc chromate induced concentration- and time-dependent increases in aneuploidy in the form of hypodiploidy, hyperdiploidy, and tetraploidy. Zinc chromate also induced centrosome amplification in a concentration- and time-dependent manner in both interphase and mitotic cells after chronic exposure, producing cells with centriolar defects. Furthermore, chronic exposure to zinc chromate induced concentration- and time-dependent increases in spindle assembly checkpoint bypass with increases in centromere spreading, premature centromere division, and premature anaphase. Last, we found that chronic exposure to zinc chromate induced a G2 arrest. All together, these data indicate that zinc chromate can induce chromosome instability after prolonged exposures.


Subject(s)
Centrosome/drug effects , Chromates/toxicity , Chromosomal Instability/drug effects , Fibroblasts/drug effects , Lung/drug effects , Spindle Apparatus/drug effects , Zinc Compounds/toxicity , Aneuploidy , Cell Line , Humans , Lung/cytology , Particle Size , Solubility
17.
Chem Res Toxicol ; 23(2): 365-72, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-20000473

ABSTRACT

Hexavalent chromium (Cr(VI)) compounds are well-established human lung carcinogens. Solubility plays an important role in their carcinogenicity with the particulate Cr(VI) compounds being the most carcinogenic. Epidemiology and animal studies suggest that zinc chromate is the most potent particulate Cr(VI) compound; however, there are few comparative data to support these observations. The purpose of this study was to compare the genotoxicity of zinc chromate with two other particulate Cr(VI) compounds, barium chromate and lead chromate, and one soluble Cr(VI) compound, sodium chromate. The clastogenic effects of barium chromate and zinc chromate were similar, but lead chromate induced significantly less damage. The levels of DNA damage measured by gamma-H2A.X foci formation were similar for the three particulate chromium compounds. Corrected for chromium uptake differences, we found that zinc chromate and barium chromate were the most cytotoxic, and lead chromate and sodium chromate were less cytotoxic. Zinc chromate was more clastogenic than all other chromium compounds, and lead chromate was the least clastogenic. There was no significant difference between any of the compounds for the induction of DNA double strand breaks. All together, these data suggest that the difference in the carcinogenic potency of zinc chromate over the other chromium compounds is not due solely to a difference in chromium ion uptake and that the zinc cation may in fact have an important role in its carcinogenicity.


Subject(s)
Bronchi/cytology , Chromium/toxicity , Mutagenicity Tests , Carcinogens, Environmental/toxicity , Cell Line , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans
18.
Comp Biochem Physiol C Toxicol Pharmacol ; 150(4): 487-94, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19632355

ABSTRACT

Humans and cetaceans are exposed to a wide range of contaminants. In this study, we compared the cytotoxic and genotoxic effects of a metal pollutant, hexavalent chromium [Cr(VI)], which has been shown to cause damage in lung cells from both humans and North Atlantic right whales. Our results show that Cr induces increased cell death and chromosome damage in lung cells from both species with increasing intracellular Cr ion levels. Soluble Cr(VI) induced less of a cytotoxic and genotoxic effect based on administered dose in right whale (Eubalaena glacialis) cells than in human (Homo sapiens) cells. Whereas, particulate Cr(VI) induced a similar cytotoxic effect but less of a genotoxic effect based on administered dose in right whale cells than in human cells. Differences in chromium ion uptake explained soluble chromate-induced cell death but not all of the soluble chromate-induced chromosome damage. Uptake differences of lead ions could explain the differences in particulate chromate-induced toxicity. The data show that both forms of Cr(VI) are less genotoxic to right whale than human lung cells, and that soluble Cr(VI) induces a similar cytotoxic effect in both right whale and human cells, while particulate Cr(VI) is more cytotoxic to right whale lung cells.


Subject(s)
Chromium/toxicity , Lung/cytology , Lung/drug effects , Animals , Atlantic Ocean , Carcinogens, Environmental/chemistry , Carcinogens, Environmental/pharmacology , Carcinogens, Environmental/toxicity , Cell Death/drug effects , Cell Line , Cell Survival/drug effects , Cells, Cultured , Chromates/pharmacology , Chromates/toxicity , Chromium/analysis , Chromium/chemistry , Chromium/pharmacology , Chromosome Aberrations/drug effects , Dose-Response Relationship, Drug , Humans , Lead/pharmacology , Lead/toxicity , Metaphase/drug effects , Particle Size , Sodium Compounds/pharmacology , Sodium Compounds/toxicity , Solubility , Whales
19.
Toxicol Appl Pharmacol ; 234(3): 293-9, 2009 Feb 01.
Article in English | MEDLINE | ID: mdl-19027772

ABSTRACT

Hexavalent chromium Cr(VI) is a respiratory toxicant and carcinogen, with solubility playing an important role in its carcinogenic potential. Zinc chromate, a water insoluble or 'particulate' Cr(VI) compound, has been shown to be carcinogenic in epidemiology studies and to induce tumors in experimental animals, but its genotoxicity is poorly understood. Our study shows that zinc chromate induced concentration-dependent increases in cytotoxicity, chromosome damage and DNA double strand breaks in human lung cells. In response to zinc chromate-induced breaks, MRE11 expression was increased and ATM and ATR were phosphorylated, indicating that the DNA double strand break repair system was initiated in the cells. In addition, our data show that zinc chromate-induced double strand breaks were only observed in the G2/M phase population, with no significant amount of double strand breaks observed in G1 and S phase cells. These data will aid in understanding the mechanisms of zinc chromate toxicity and carcinogenesis.


Subject(s)
Chromates/toxicity , Chromosomal Instability , DNA Breaks, Double-Stranded , DNA/drug effects , Fibroblasts/drug effects , Lung/drug effects , Mutagens/toxicity , Zinc Compounds/toxicity , Ataxia Telangiectasia Mutated Proteins , Cell Cycle/drug effects , Cell Cycle Proteins/metabolism , Cell Line , Cell Survival/drug effects , DNA/metabolism , DNA-Binding Proteins/metabolism , Dose-Response Relationship, Drug , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Lung/metabolism , Lung/pathology , MRE11 Homologue Protein , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Tumor Suppressor Proteins/metabolism , Up-Regulation
20.
Mar Pollut Bull ; 56(8): 1416-21, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18599091

ABSTRACT

The endangered Western population of the Steller sea lion declined for three decades for uncertain reasons. We present baseline data of metal concentrations in pups as a first step towards investigating the potential threat of developmental exposures to contaminants. Seven metals were investigated: arsenic, cadmium, silver, aluminum, mercury, lead and vanadium. Vanadium was detected in only a single blubber sample. Mercury appears to be the most toxicologically significant metal with concentrations in the liver well above the current action level for mercury in fish. The concentrations of aluminum, arsenic, silver, cadmium and lead were present in one-fourth to two-thirds of all samples and were at either comparable or below concentrations previously reported. Neither gender nor region had a significant effect on metal burdens. Future work should consider metal concentrations in juveniles and adults and toxicological studies need to be performed to begin to assess the toxicity of these metals.


Subject(s)
Metals, Heavy/metabolism , Sea Lions/metabolism , Water Pollutants, Chemical/metabolism , Animals , Female , Male , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...